SEC Form 4 · accession 0001171843-16-011905
Xenon Pharmaceuticals Inc. · XENE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank A Holler
Director
Period of report
Aug 19, 2016
Accepted (ET)
Aug 23, 2016 · 4:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001582313
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Aug 19, 2016 | S | 11,938 | $7.651 | D | 145,869 | D | |
| Common Shares | holding | — | — | — | 1,184 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.